A Phase III, Open-label, Multicenter Study to Evaluate Long-term Immunogenicity and Boostability of Immune Responses in Adults who Received Different Primary Vaccination Schedules of Pre-exposure Prophylaxis with Purified Chick-Embryo Cell Rabies Vaccine Administered Concomitantly or Separately from a Japanese Encephalitis Vaccine
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 10 Apr 2017
At a glance
- Drugs Rabies vaccine (Primary)
- Indications Rabies
- Focus Pharmacodynamics; Registrational
- Sponsors GlaxoSmithKline Biologicals; Novartis Vaccines
- 23 Nov 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 13 Oct 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 17 Jul 2015 New trial record